Moderna testing 2 booster shots to protect against Omicron variant, expects data soon

US-based pharmaceutical giant Moderna is studying two booster shot options designed to anticipate mutations similar to the Omicron strain of the coronavirus, which has been designated as a variant of concern by the WHO.

It is already working to test the ability of the current vaccine dose to neutralise the Omicron variant and data is expected in the coming weeks.

“Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant,” the company said in a statement.

The first candidate (mRNA-1273.211) includes several mutations present in the Omicron variant that were also present in the Beta variant of concern1. Moderna said it has completed dosing in a potentially pivotal safety and immunogenicity study of mRNA-1273.211 at the 50 µg (N=300) and 100 µg (N=584) dose levels.

ALSO READ | PM Modi chairs key meet on Covid-19, vaccination status amid concerns over Omicron variant

A second multi-valent candidate (mRNA-1273.213) includes many of the mutations present in the Omicron variant that were also present in the Beta and Delta variants2. The company has completed dosing at the 100 µg (N=584) dose level and also plans to explore the 50 µg dose level in approximately 584 participants.

Moderna said it will “rapidly advance” an Omicron-specific booster shot, much like its Beta- and Delta-specific boosters.

“A booster dose of an authorised vaccine represents the only currently available strategy for boosting waning immunity,” the company said.

The new coronavirus variant B.1.1.529, dubbed Omicron, was first reported to the WHO from South Africa on November 24, and has also been identified in Botswana, Belgium, Hong Kong and Israel.

ALSO READ | WHO names new Covid variant Omicron; South Africa says travel bans unjustified | Top points

Global authorities have reacted with alarm to the new variant, with the United States, UK and the EU among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant.

Pfizer and BioNTech said they expect more data on the Omicron strain to determine whether its Covid-19 vaccine would have to be reworked. Johnson and Johnson also said it is closely monitoring emerging strains of coronavirus and is testing the effectiveness of its shot against the new variant.

(With inputs from Agencies)



* This article was originally published here

Comments

Post a Comment

Popular posts from this blog

Katrina Kaif knows Manvinder for 3 years and her sister – Vicky Kaushal

The man who threatened to kill Katrina Kaif and Vicky Kaushal was immediately arrested by the Mumbai Police. The accused was named Manvinder, who was described as a struggling actor as well as a Jabra fan of Katrina Kaif. Now accused Manvinder Singh’s lawyer Sandeep Sharekhane has claimed that his client neither stocked Katrina Kaif nor threatened to kill Vicky. He has told all these allegations against him as false, while the police remand copy states that accused Manvinder Singh had sent a message to Vicky Kaushal to keep him at gunpoint and the date of his RIP i.e. Rest in Peace is final. – Katrina and her family have known her for 3 years, her lawyer has told, ‘Katrina Kaif and her family have known my client very well for 3 years. Manvinder was in touch with Katrina Kaif and her family since 2019, both of them used to have conversations through phone and social media, and he was in constant touch with his sister Ayesha Kaif. A lot of comments have been deleted by ...
Read more

Redmi 9 Activ with up to 6GB RAM, 5000mAh battery now up for sale, price starts at Rs 9,499

Redmi has finally launched its new budget smartphone in India, called Redmi 9 Activ. The device is up for sale in the country and comes with few improvements over the vanilla Redmi 9. Most of the specifications remain the same though, as does the price point of the new smartphone The highlight among these include a MediaTek Helio G35 processor, a larger RAM than before and a 5,000mAh battery. Here is a look at all that the new Redmi 9 Activ has to offer and the price at which it will be available.Redmi 9 Activ price and availabilityRedmi 9 Activ has been launched at Rs 9,499 for the starting variant that comes with 4GB RAM and 64GB storage. There is also a 6GB RAM option with 128GB storage, that retails for Rs 10,999. The Redmi smartphone is available in three colour options – Carbon Black, Coral Green, and Metallic Purple.Interested buyers can purchase the new Redmi 9 Activ through Amazon, Mi.com, Mi Home, and Mi Studio stores.Redmi 9 Activ specificationsAs was tipped before its ...
Read more

India fast bowler Abhimanyu Mithun retires from first-class cricket: Representing my country biggest achievement

31-year-old Abhimanyu Mithun had played 4 Tests and 5 ODis between 2010 and 2011 for India. The Karnataka pacer has decided to call time on his first-class career. Abhimanyu Mithun played 4 Tests and 5 ODIs for India (PTI Photo)HIGHLIGHTS31-year-old Abhimanyu Mithun has called time on first-class careerMithun played 4 Tests and 5 ODIs for India between 2010 and 2011Mithun has picked up more than 500 wickets for Karnataka in domestic cricketIndia fast bowler Abhimanyu Mithun on Thursday announced retirement from first-class cricket, saying he wishes to pursue other avenues in his career. Mithun, who made his India debut in 2010, played 4 Tests and 5 ODIs while picking up 12 wickets at the international level. The Karnataka fast bowler last played for India in December 2011. Abhimanyu Mithun, who had been a workhorse for Karnataka in domestic cricket, played 103 first-class matches, 96 List A games and 74 T20s, picking up more than 500 wickets in 13-year-long career.Abhimanyu Mithun, 31,...
Read more